2026 marks a turning point for the French HealthTech industry. According to the France HealthTech 2026 Panorama, published in January 2026 by France Biotech and EY, digital health now accounts for 40% of the sector, driven by the rise of DeepTech.
But this growing maturity brings new challenges. Compliance is no longer simply a technical requirement to tick off a checklist. It has become a fundamental part of business strategy.
At Novity, we help HealthTech companies turn regulatory constraints into opportunities for sustainable growth. Our Product & Software Engineering approach focuses on building systems where technical compliance directly supports business objectives.
To illustrate this approach, let's examine one of our client projects: supporting the international expansion of a digital pathology leader.
The challenge: Scaling in a highly regulated HealthTech environment
For a post-Series B scale-up looking to expand into new markets across Europe and North America, regulatory complexity should not become a barrier to product delivery.
Our client, a major player in precision medicine, faced three interconnected challenges.
- Data sovereignty: With Decree 2026-209, requirements for certified health data hosting providers (Hébergeurs de Données de Santé, or HDS) have become more stringent. Data sovereignty is now a prerequisite for hospital deployments.
- Standardising software delivery: Developing bespoke solutions for every customer was no longer sustainable. The company needed a robust core product capable of processing large volumes of medical imaging data.
The Solution: Compliance-by-Design Software Engineering
To support these ambitions, Novity embedded autonomous Product Engineers directly into the client's teams.
The objective went beyond writing code. It was about turning complex algorithms into reliable, production-ready systems capable of delivering clinical value, supported by MLOps practices.
Our collaboration was built around four key pillars :
- Data Security and Pseudonymisation
We implemented strict protocols to protect patient information and anonymise shared medical images, an essential requirement for international clinical research.
These measures helped establish a more secure framework for processing and sharing sensitive healthcare data
- Quality Assurance and Certification
In healthcare, software quality is critical.
Our QA specialists introduced rigorous testing processes, including web service testing with Postman and test automation, to support the maintenance of ISO 27001 certification.
This approach helped reinforce the reliability and security of the platform as it evolved.
- Healthcare System Interoperability
The client's Platform as a Service (PaaS) needed to integrate smoothly into the daily workflows of pathologists, regardless of their geographical location.
Interoperability was therefore essential to ensuring that the platform could operate effectively across different healthcare environments.
- A Culture of Collaborative Delivery
Our engineers did more than complete Jira tickets.
They actively participated in backlog refinement and technical estimation sessions, challenging each feature from both a performance and security perspective.
This close integration helped ensure that technical decisions remained aligned with the client's product objectives and regulatory requirements.
The results: Secure growth and international recognition
By combining engineering agility with a rigorous understanding of healthcare requirements, our client was able to turn complex challenges into tangible progress.
- An Accelerated Product Roadmap : By standardising functionality using Java and TypeScript, the team strengthened its ability to accommodate customer requirements without compromising the stability of the core platform.
- International Recognition: The company was selected for the French Tech 2030 programme and received multiple Best in KLAS awards, internationally recognised distinctions in healthcare technology.
- Greater System Maturity: AI evolved from experimentation into an integrated capability that accelerates diagnostic processes while protecting patient data, demonstrating how robust software engineering can support international expansion without compromising security or product quality.
HealthTech in 2026: Towards a New Standard of Trust
As highlighted in Deloitte's 2026 Life Sciences and Health Care Outlook, the healthcare sector is approaching a decisive moment for AI infrastructure.
The industry is moving beyond the limitations of traditional SaaS models, towards longer R&D cycles where risk management plays an increasingly central role.
For Novity, the objective is clear: help ambitious HealthTech companies scale without allowing technical complexity or regulatory requirements to slow their progress.
By integrating experienced engineers who understand the SREN legislation and the challenges of translating technological innovation into clinical practice, we enable our clients to focus on what matters most: advancing treatments and modernising diagnostics on a global scale.
Sources
- France BioTech - 23e édition du Panorama France HealthTech 2026
- La mission French Tech - Programme FrenchTech 2030
- KLAS Research - 2026 Best in KLAS Awards, Digital Pathology (Europe)
- Deloitte Center for Health Solutions - 2026 Life Sciences and Health Care Industry Outlooks





